1. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). Issue 1 (13th January 2021) Authors: Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Ok... Other Names: author non-byline.; Miyoshi Hideaki author non-byline.; Abiko Atsuko author non-byline.; Nagai Sou author non-byline.; Yanagisawa Katsuyuki author non-byline.; Kijima Hiromichi author non-byline.; Taneda Shinji author non-byline.; Saitoh Shigeyuki author non-byline.; Ikeda Daisuke author non-byl... Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). Issue 1 (13th January 2021) Authors: Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Ok... Other Names: author non-byline.; Miyoshi Hideaki author non-byline.; Abiko Atsuko author non-byline.; Nagai Sou author non-byline.; Yanagisawa Katsuyuki author non-byline.; Kijima Hiromichi author non-byline.; Taneda Shinji author non-byline.; Saitoh Shigeyuki author non-byline.; Ikeda Daisuke author non-byl... Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). Issue 1 (13th January 2021) Authors: Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Ok... Other Names: author non-byline.; Miyoshi Hideaki author non-byline.; Abiko Atsuko author non-byline.; Nagai Sou author non-byline.; Yanagisawa Katsuyuki author non-byline.; Kijima Hiromichi author non-byline.; Taneda Shinji author non-byline.; Saitoh Shigeyuki author non-byline.; Ikeda Daisuke author non-byl... Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). Issue 1 (13th January 2021) Authors: Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Ok... Other Names: author non-byline.; Miyoshi Hideaki author non-byline.; Abiko Atsuko author non-byline.; Nagai Sou author non-byline.; Yanagisawa Katsuyuki author non-byline.; Kijima Hiromichi author non-byline.; Taneda Shinji author non-byline.; Saitoh Shigeyuki author non-byline.; Ikeda Daisuke author non-byl... Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66). Issue 3 (3rd May 2022) Authors: Yokoyama, Hiroki; Araki, Shin-ichi; Yamazaki, Katsuya; Kawai, Koichi; Shirabe, Shin-Ichiro; Oishi, Mariko; Kanatsuka, Azuma; Yagi, Noriharu; Kabata, Daijiro; Shintani, Ayumi; Maegawa, Hiroshi Other Names: author non-byline.; Hasegawa Atsushi author non-byline.; Kato Masakazu author non-byline.; Kurihara Yoshio author non-byline.; Manda Naoki author non-byline.; Miyazawa Kazuhiro author non-byline.; Moriai Tetsuya author non-byline.; Tsuchida Kenichi author non-byline.; Yamada Daishiro author non-... Journal: BMJ open diabetes research and care Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗